|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$8,243
|
N/A
|
National Cancer Institute
|
|
TAS::75 0849::TAS Incremental Funding
|
261200800001E-51
|
$271,391,560
|
$117,977
|
Heimbrook, David
|
SAIC-FREDERICK, INC.
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-37
|
$7,216,850
|
$288,674
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-42
|
$3,603,798
|
$36,038
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Continuation of follow-up of DES-exposed cohorts
|
ZIA CP010168-00020
|
$2,241,379
|
$224,138
|
Hoover, Robert
|
DCEG (NCI)
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$2,192,713
|
$109,636
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Laboratory of Translational Genomics
|
ZIA CP010201-10410
|
$1,892,992
|
$189,299
|
Chanock, Stephen
|
DCEG (NCI)
|
|
Chromatin Structure and Gene Expression
|
ZIA BC 005450
|
$1,467,577
|
$220,137
|
Hager, Gordon
|
CCR (NCI)
|
|
Post GWA Studies in Testicular Germ Cell Tumors
|
5U01CA164947-02
|
$1,451,724
|
$1,451,724
|
Nathanson, Katherine
|
UNIVERSITY OF PENNSYLVANIA
|
|
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities
|
5R01CA157823-02
|
$1,414,272
|
$1,414,272
|
Travis, Lois
|
UNIVERSITY OF ROCHESTER
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
$12,071
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
|
4R44CA217587-02
|
$1,165,750
|
|
PEREZ, KRISTY
|
CIVATECH ONCOLOGY, INC.
|
|
UCLA SPORE in Prostate Cancer
|
3P50CA092131-15S1
|
$1,162,609
|
|
REITER, ROBERT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
SPORE in Genitourinary Cancer
|
3P50CA091846-15S1
|
$1,162,609
|
|
DINNEY, COLIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
SPORE in Breast Cancer
|
3P50CA098131-16S1
|
$1,162,609
|
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
|
4R44CA224460-02
|
$1,111,364
|
|
DAUNCH, WILLIAM
|
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.
|
|
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
|
3U01DK108328-04S2
|
$1,000,000
|
|
YUAN, YING
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Ultra-High Content Analysis (UHCA) of Single Cells in Tissue: 60+ channel immunofluorescence labeling kits and companion imaging software for everyone
|
4R44CA224994-02
|
$749,974
|
|
NEDERLOF, MICHEL
|
QUANTITATIVE IMAGING SYSTEMS, LLC
|
|
Novel Fluorescent Diagnostic Agents for Detection, Staging, andIntraoperative Imaging of Tumors
|
4R44CA217528-02
|
$710,496
|
|
SRINIVASAN, RAVI
|
ONCONANO MEDICINE, INC.
|
|
A real-time, cost-effective, accurate UV measurement and sun protection system to prevent and reduce the incidence of sunburn in high-risk consumers.
|
4R44CA224658-02
|
$686,491
|
|
MEITL, MATTHEW
|
WEARIFI, INC.
|
|
DICER1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural
|
ZIA CP010144-10548
|
$668,605
|
$33,430
|
Stewart, Douglas
|
DCEG (NCI)
|
|
Chemistry and Biology of Platinum Anticancer Drugs
|
5R01CA034992-31
|
$639,282
|
$127,856
|
Lippard, Stephen
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$597,349
|
$59,735
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Annual anal sampling using DNA screening to identify men who have sex with men at increased risk for anal cancer
|
7R01CA215403-02
|
$551,568
|
|
NYITRAY, ALAN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Genetic control of susceptibility of testicular cancer
|
7R01CA075056-14
|
$527,247
|
$527,247
|
NADEAU, JOSEPH
|
PACIFIC NORTHWEST RESEARCH INSTITUTE
|
|
SPORE in Skin Cancer
|
3P50CA121973-10S2
|
$500,000
|
|
KIRKWOOD, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Function of Steroid Receptors in Subcellular Compartments
|
ZIA BC 010027
|
$489,192
|
$97,838
|
Hager, Gordon
|
CCR (NCI)
|
|
Multilevel Resilience Trajectories in the Transition to Cancer Survivorship
|
4UH3CA220642-02
|
$402,405
|
|
PARK, CRYSTAL
|
UNIVERSITY OF CONNECTICUT STORRS
|
|
Radiation dose- response and second primary cancers of stomach, esophagus, and pa
|
ZIA CP010131-04134
|
$389,276
|
$38,928
|
Morton, Lindsay
|
DCEG (NCI)
|
|
Circulating plasma tumor DNA as a biomarker for early stage breast cancer
|
7R01CA194024-03
|
$378,539
|
|
PARK, BEN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Clinical and genetic studies of familial testicular cancer
|
ZIA CP010144-07070
|
$367,585
|
$367,585
|
Loud, Jennifer
|
DCEG (NCI)
|
|
Imaging and Radiation Oncology Core (IROC) Group
|
3U24CA180803-05S1
|
$335,460
|
|
FOLLOWILL, DAVID
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Cancer Therapy-induced Long-term Bone Marrow Injury
|
7R01CA122023-11
|
$308,813
|
|
ZHOU, DAOHONG
|
UNIVERSITY OF FLORIDA
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
3P30CA023074-38S4
|
$300,000
|
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
Stephenson Cancer Center - Cancer Center Support Grant
|
3P30CA225520-01S2
|
$299,724
|
|
MANNEL, ROBERT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S8
|
$293,284
|
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Clinical Fellowship Training Program
|
ZIE BC 011023
|
$276,895
|
$13,845
|
Pinto, Peter
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA013696-44S9
|
$250,000
|
|
SCHWARTZ, GARY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Studying the initiation, progression and therapy of lung cancer in mouse models
|
3R01CA131261-09S2
|
$249,999
|
|
MCMAHON, MARTIN
|
UNIVERSITY OF UTAH
|
|
The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice through Effective Communication of Personalized Cancer Risk
|
4R00CA207872-03
|
$248,995
|
|
RYSER, MARC
|
DUKE UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S3
|
$246,169
|
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
In vivo Imaging Analysis of Steroid/Nuclear Receptor Function
|
ZIA BC 010308
|
$244,596
|
$24,460
|
Hager, Gordon
|
CCR (NCI)
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S7
|
$241,885
|
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Testicular cancer among US Servicemen
|
ZIA CP010126-01202
|
$237,234
|
$237,234
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA042014-29S9
|
$228,331
|
|
ULRICH, CORNELIA
|
UNIVERSITY OF UTAH
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S6
|
$228,108
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Physical Activity Platform to Improve Bone Health in Cancer Survivors
|
6R43CA224412-02
|
$224,098
|
|
SKINNER, CATHERINE
|
THRIVORS, INC.
|
|
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
|
3R44CA200186-03S1
|
$209,717
|
|
HUMBLET, VALERIE
|
COLLAGEN MEDICAL, LLC
|
Total relevant funding to Testes for this search: $5,864,134
|